Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « MeshFr.i » - entrée « Protéine amyloïde A sérique »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Protéine adaptatrice de signalisation NOD2 < Protéine amyloïde A sérique < Protéine bcl-X  Facettes :

List of bibliographic references indexed by Protéine amyloïde A sérique

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000829 (2019) Ahmet Ilbay [Turquie] ; Abdulsamet Erden ; Alper Sari ; Berkan Armagan ; Burak Yasin Aktas ; Ertugrul Cagri Bolek ; Umut Kalyoncu ; Omer KaradagSuccessful Treatment of Amyloid A-Type Amyloidosis Due to Behçet Disease With Tocilizumab.
000895 (2019) Simon Galmiche [France] ; David Buob [France] ; Soraya Fellahi [France] ; Jean-Philippe Bastard [France] ; Gilles Grateau [France] ; Sophie Georgin-Lavialle [France]Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis.
001133 (2018) Yumi Yamada ; Toshinori Ueno ; Taisuke Irifuku ; Ayumu Nakashima ; Shigehiro Doi ; Tatsuo Ichinohe ; Takao MasakiTocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
001202 (2018) Guoqiang Zhang [États-Unis] ; Hidetaka Hara [États-Unis] ; Takayuki Yamamoto [États-Unis] ; Qi Li [États-Unis] ; Abhijit Jagdale [États-Unis] ; Yong Li [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Hayato Iwase [États-Unis]Serum amyloid a as an indicator of impending xenograft failure: Experimental studies.
001335 (2018) Kazuha Kizaki [Japon] ; Fumiharu Yamashita [Japon] ; Tomoya Hayashi [Japon] ; Noboru Funakoshi [Japon]Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
001600 (2017) Hiroshi Uda [Japon] ; Osamu Saiki [Japon]Tocilizumab postpones the start of hemodialysis compared to conventional oral treatment in amyloid A amyloidosis patients with advanced renal insufficiency by suppressing serum SAA levels.
001702 (2017) Akira Yamagata [Japon] ; Takahiro Uchida [Japon] ; Yuji Yamada [Japon] ; Takashi Nakanishi [Japon] ; Kazue Nagai [Japon] ; Toshihiko Imakiire [Japon] ; Naoki Oshima [Japon] ; Hiroo Kumagai [Japon]Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.
001912 (2017) Tao Li [États-Unis] ; Whayoung Lee ; Hidetaka Hara ; Cassandra Long ; Mohamed Ezzelarab ; David Ayares ; Hai Huang ; Yi Wang ; Charles T. Esmon ; David K C. Cooper ; Hayato IwaseAn Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.
001B32 (2016) Jaka Ostrovršnik [Slovénie] ; Alojzija Ho Evar [Slovénie] ; Boris Lestan [Slovénie] ; Snežna Sodin Emrl [Slovénie] ; Katja Lakota [Slovénie] ; Matija Tomši [Slovénie]Long-term follow-up on tocilizumab treatment of AA amyloidosis secondary to polyarteritis nodosa.
001C24 (2016) Cem Gabay [Suisse] ; Iain B. Mcinnes [Royaume-Uni] ; Arthur Kavanaugh [États-Unis] ; Katie Tuckwell [Royaume-Uni] ; Micki Klearman [États-Unis] ; Jennifer Pulley [Royaume-Uni] ; Naveed Sattar [Royaume-Uni]Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
001E58 (2015) Sedat Yilmaz [Turquie] ; Muhammet Cinar [Turquie] ; Ismail Simsek [Turquie] ; Hakan Erdem [Turquie] ; Salih Pay [Turquie]Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever.
002049 (2015) Iain B. Mcinnes [Royaume-Uni] ; Liz Thompson [Royaume-Uni] ; Jon T. Giles [États-Unis] ; Joan M. Bathon [États-Unis] ; Jane E. Salmon [États-Unis] ; Andre D. Beaulieu [Canada] ; Christine E. Codding [États-Unis] ; Timothy H. Carlson [États-Unis] ; Christian Delles [Royaume-Uni] ; Janet S. Lee [États-Unis] ; Naveed Sattar [Royaume-Uni]Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.
002212 (2015) Shunichi Fujita [Japon] ; Nami Kosaka [Japon] ; Takafumi Mito [Japon] ; Hiroaki Hayashi [Japon] ; Yoshitaka Morita [Japon]Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis
002344 (2014) Ippei Miyagawa [Japon] ; Shingo Nakayamada ; Kazuyoshi Saito ; Kentaro Hanami ; Masao Nawata ; Norifumi Sawamukai ; Kazuhisa Nakano ; Kunihiro Yamaoka ; Yoshiya TanakaStudy on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
002825 (2013) Alojzija Ho Evar [Slovénie] ; Boris Lestan ; Snežna Sodin Šemrl ; Katja Lakota ; Nika Kojc ; Nataša Poto Nik ; Matija TomšiAA amyloidosis in a polyarteritis nodosa patient treated with tocilizumab.
002F27 (2013) Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse]Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis
003422 (2012) Yoshinari Hattori [Japon] ; Yoshifumi Ubara ; Keiichi Sumida ; Rikako Hiramatsu ; Eiko Hasegawa ; Masayuki Yamanouchi ; Noriko Hayami ; Tatsuya Suwabe ; Junichi Hoshino ; Naoki Sawa ; Kenichi Oohashi ; Kenmei TakaichiTocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis.
003886 (2011) César Magro-Checa [Espagne] ; Antonio Navas-Parejo Casado ; Elena Borrego-García ; Enrique Raya-Álvarez ; José Luis Rosales-Alexander ; Juan Salvatierra ; Trinidad Caballero-Morales ; Mercedes G Mez-MoralesSuccessful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis.
003940 (2011) K. Immonen ; M. Kauppi ; M. HakalaExperiences on the use of biological drugs in psoriatic arthritis-associated amyloidosis.
004244 (2006) Yasuaki Okuda [Japon] ; Kiyoshi Takasugi [Japon]Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
004317 (????) Thirusha Lane [Royaume-Uni] ; Julian D. Gillmore [Royaume-Uni] ; Ashutosh D. Wechalekar [Royaume-Uni] ; Philip N. Hawkins [Royaume-Uni] ; Helen J. Lachmann [Royaume-Uni]Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Protéine amyloïde A sérique" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Protéine amyloïde A sérique" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Protéine amyloïde A sérique
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021